KELLY JOHNSON: Open Payments
NPI 1851932404 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,573 in 134 payments from 24 companies in 2025. Trend: 2023 $1,477 · 2024 $2,397 · 2025 $2,573
Food & beverage: $2,573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $490 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $431 |
| Janssen Biotech, Inc. | 20 | $414 |
| Madrigal Pharmaceuticals | 10 | $210 |
| Lilly USA, LLC | 10 | $156 |
| PFIZER INC. | 9 | $141 |
| VIVUS LLC | 4 | $78 |
| QOL Medical, LLC | 2 | $76 |
| Sumitomo Pharma America, Inc. | 1 | $71 |
| Medtronic, Inc. | 1 | $70 |
Products named: TREMFYA, RINVOQ, ENTYVIO, REZDIFFRA, OMVOH, EOHILIA, VELSIPITY, LINZESS.
Industry payments across FL — which companies pay providers there.
